Epicorynoxidine is primarily studied for its potential pharmacological effects, particularly in the area of central nervous system modulation. It has shown interest in research related to neuroactive properties, possibly influencing neurotransmitter systems involved in mood regulation and neuronal signaling. Due to its structural similarity to other indole alkaloids with known biological activity, it is investigated for possible use in developing agents that target neurological pathways, including those related to anxiety, depression, or neurodegenerative conditions. Its application remains largely within preclinical research, where it serves as a lead compound for understanding receptor interactions and for the design of novel therapeutic agents.